152 related articles for article (PubMed ID: 10521081)
1. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease.
Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Zuckerman L; Schlegel R; Williamson P
J Lab Clin Med; 1999 Oct; 134(4):352-62. PubMed ID: 10521081
[TBL] [Abstract][Full Text] [Related]
2. Coagulation changes in individuals with sickle cell trait.
Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
[TBL] [Abstract][Full Text] [Related]
3. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
4. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
5. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
6. Soluble P-selectin and vascular endothelial growth factor in steady state sickle cell disease: relationship to genotype.
Blann AD; Mohan JS; Bareford D; Lip GY
J Thromb Thrombolysis; 2008 Apr; 25(2):185-9. PubMed ID: 18080800
[TBL] [Abstract][Full Text] [Related]
7. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of some coagulation parameters in steady state HBSC disease patients.
Ajuwon MD; Olayemi E; Benneh AA
Pan Afr Med J; 2014; 19():289. PubMed ID: 25870744
[TBL] [Abstract][Full Text] [Related]
9. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
10. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
Ogedengbe OK; Akinyanju O
West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
[TBL] [Abstract][Full Text] [Related]
12. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
13. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
14. The varicella-autoantibody syndrome.
Josephson C; Nuss R; Jacobson L; Hacker MR; Murphy J; Weinberg A; Manco-Johnson MJ
Pediatr Res; 2001 Sep; 50(3):345-52. PubMed ID: 11518821
[TBL] [Abstract][Full Text] [Related]
15. C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with plasmodium falciparum.
Arinola G; Ezeh C
Iran J Immunol; 2007 Mar; 4(1):44-9. PubMed ID: 17652843
[TBL] [Abstract][Full Text] [Related]
16. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
17. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
[TBL] [Abstract][Full Text] [Related]
18. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
19. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
[TBL] [Abstract][Full Text] [Related]
20. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.
Reverter JC; Tàssies D; Font J; Monteagudo J; Escolar G; Ingelmo M; Ordinas A
Arterioscler Thromb Vasc Biol; 1996 Nov; 16(11):1319-26. PubMed ID: 8911269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
